Human medicines European Public Assessment Report (EPAR): Urorec, silodosin, Revision: 6, Authorised
Related Biotechnology, Pharmaceutical and Healthcare News
- Human medicines European Public Assessment Report (EPAR): Incivo, telaprevir, Revision: 7, Authorised
- Human medicines European Public Assessment Report (EPAR): Orencia, abatacept, Revision: 14, Authorised
- Human medicines European Public Assessment Report (EPAR): Viramune, nevirapine, Revision: 30, Authorised
- Human medicines European Public Assessment Report (EPAR): Celsentri, maraviroc, Revision: 12, Authorised
- Human medicines European Public Assessment Report (EPAR): Naglazyme, galsulfase, Revision: 9, Authorised
Original Article: Human medicines European Public Assessment Report (EPAR): Urorec, silodosin, Revision: 6, Authorised
NEXT ARTICLE
More From BioPortfolio on "Human medicines European Public Assessment Report (EPAR): Urorec, silodosin, Revision: 6, Authorised"
Search BioPortfolio: